# DigiTx Partners

> DigiTx Partners is a VC fund backing Health Care and Artificial Intelligence. See 31 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Brisbane, United States
- Total investments: 31
- Last investment: Jul 2026
- Lead investor: 48%
- Fund size: $75M
- Last fund: Oct 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/digitxpartners/
- X (Twitter): https://twitter.com/DigiTx_Partners
- Website: http://www.digitxpartners.com/
- Facebook: https://www.facebook.com/digitxpartners/

DigiTx Partners is a VC fund in Brisbane focused on Health Care and Artificial Intelligence. At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.

## Contacts

5 contacts available for DigiTx Partners. Shizune tracks 2 team members at DigiTx Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/digitx-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.7M–$7.8M |
| Series A | $4M–$23M |
| Series B | $6M–$43M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 18 | 58% |
| Artificial Intelligence | 9 | 29% |
| Medical | 8 | 26% |
| Software | 7 | 23% |
| Medical Device | 6 | 19% |

43 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 35% |
| Seed | 9 | 29% |
| Series B | 4 | 13% |
| Series C | 2 | 6% |
| Pre-Seed | 1 | 3% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 22 | 71% |
| Canada | 1 | 3% |
| Finland | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Kim | CEO & Managing Director | 19 | https://shizune.co/investors/profile/david-kim-3 |
| Miraj Sanghvi | Partner | 3 | https://shizune.co/investors/profile/miraj-sanghvi |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biobase | The Agentic OS & Infrastructure Layer for Clinical Data |  | Pre-Seed | Jul 08, 2026 |  |
| Auxira Health | Auxira Health is committed to providing virtual practice extensions that seem like a natural extension of your team, bringing order to the chaos of modern healthcare. | $7.8M | Seed | Dec 15, 2025 |  |
| Neon Health | Neon accelerates patient access to critical care by jumping through all the hoops to onboard and adhere to life-saving drugs, treatments. | $6M | Seed | Sep 02, 2025 |  |
| Cerula Care | Cerula Care specializes in behavioral health services for people with chronic conditions. | $5.5M | Seed | Feb 12, 2025 |  |
| StrokeDx | StrokeDx develops rapid and portable devices to transform how strokes are diagnosed. The company's full-time software engineering team works on novel algorithms using machine learning and AI approaches to fuel the diagnostic accuracy and imaging capabilities of the StrokeDx sensor. | $5M | Seed | May 23, 2024 |  |
| CardioSignal | We develop groundbreaking solutions for the detection of heart diseases. CardioSignal is a mobile application and a certified medical device for the detection of atrial fibrillation. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development. CardioSignal is a brand and a product byPrecordior. www.cardiosignal.com | $10M | Series A | Jan 23, 2024 |  |
| Rune Labs | Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developersthe performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials.Rune Labs was founded in 2018 and is headquartered in San Francisco, California. | $12M | Venture - Series Unknown | Jan 11, 2024 |  |
| Ciba Health | Ciba Health is a personalized digital therapeutics and virtual care platform. The company utilizes a precision health approach to treat and reverse chronic conditions while optimizing the physical and mental well-being of our patients | $10M | Series A | Dec 04, 2023 |  |
| Tali AI | Tali AI is an impact-oriented company that provides physicians with a voice-enabled virtual assistant that is placed over their electronic health records. The system dictates notes directly into the EHR to add information about patients and drugs. The company's contact mode is at its physical address. |  | Seed | Nov 08, 2023 |  |
| FIGUR8 | FIGUR8 is an MIT spin-off company, creating the most advanced wearable musculoskeletal (MSK) technology on the market. The solution combines Smart Biosensors, Intuitive Software and AI to analyze and advance musculoskeletal health. Our solution accurately pinpoints the source of MSK pathology and provides essential data to enhance patient-centricrecovery. Value is recorded across the entire episode of care, from injury through full recovery. FIGUR8 technology aids in significantly reducing the cost of care, improving access, and empowering patients to take control of their personal MSK health. | $25M | Series A | Aug 08, 2023 |  |

10 of 31 investments shown.

## Co-investors
- [Artis Ventures](https://shizune.co/investors/profile/artis) — VC Fund, 3 deals together
- [Moment Ventures](https://shizune.co/investors/profile/moment-ventures) — VC Fund, 3 deals together
- [Cigna Ventures](https://shizune.co/investors/profile/cigna-ventures) — VC Fund, 2 deals together
- [City Light Capital](https://shizune.co/investors/profile/city-light-capital) — VC Fund, 2 deals together
- [Eclipse](https://shizune.co/investors/profile/eclipse-ventures) — VC Fund, 2 deals together
- [Esplanade Ventures](https://shizune.co/investors/profile/esplanade-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Finland](https://shizune.co/investors/medical-vc-funds-finland)
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)
- [Mobile Apps VC Funds in Finland](https://shizune.co/investors/mobile-apps-vc-funds-finland)
- [Medical Device VC Funds in Finland](https://shizune.co/investors/medical-device-vc-funds-finland)

## FAQ

### What does DigiTx Partners invest in?

DigiTx Partners invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Series A and Seed stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is DigiTx Partners's check size?

DigiTx Partners typically joins rounds of $2.7M–$7.8M at Seed, $4M–$23M at Series A and $6M–$43M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DigiTx Partners participates in.

### How do I contact DigiTx Partners?

Public channels for DigiTx Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DigiTx Partners?

The team at DigiTx Partners includes David Kim (CEO & Managing Director) and Miraj Sanghvi (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co